The Board denied service connection for diabetes mellitus type II, prostate cancer, and peripheral neuropathy in the right and left upper and lower extremities as there was no evidence of an in-service injury or disease related to these conditions.
The deciding factor: There is no competent or credible evidence that the Veteran was exposed to herbicides during service, and the evidence does not show that any of the claimed conditions were incurred in or otherwise related to his active military service.
- Claimed conditions
- Diabetes Mellitus Type II, Prostate Cancer, Right Lower Extremity Peripheral Neuropathy, Left Lower Extremity Peripheral Neuropathy, Right Upper Extremity Peripheral Neuropathy, Left Upper Extremity Peripheral Neuropathy
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- June 6, 2025
- Citation
- A25050348
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board denied an initial increased rating for diabetes mellitus type II and remanded the claims for service connection for obstructive sleep apnea, right shoulder strain with acromioclavicular joint osteoarthritis and tendinitis, cervical spine spondylosis, left knee degenerative arthritis, right knee degenerative arthritis, and thoracolumbar scoliosis and lumbar spine degenerative changes.
- Partly granted
The Board denied a rating greater than 70 percent for PTSD, granted an earlier effective date of August 14, 2024, for the grant of a 70 percent rating for PTSD, and denied other claims including entitlement to an effective date prior to April 3, 2025, for the grant of a 100 percent rating evaluation for CAD.
- Dismissed
The appeals for service connection for insomnia, bilateral hearing loss, tinnitus, and polycythemia vera were dismissed due to procedural issues. The remaining claims are remanded for further development.
- Partly granted
The Board granted an effective date of March 15, 2023, for a 40 percent evaluation for service-connected prostate cancer and earlier dates for the awards of service connection for anterior and posterior trunk scars.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.